APA (7th ed.) Citation

Zhu, L., Butterton, J., Persson, A., Stonier, M., Comisar, W., Panebianco, D., . . . Bertz, R. (2010). Pharmacokinetics and safety of twice-daily atazanavir 300 mg and raltegravir 400 mg in healthy individuals. Antiviral therapy, 15(8), 1107-1114. https://doi.org/10.3851/IMP1673

Chicago Style (17th ed.) Citation

Zhu, Li, Joan Butterton, Anna Persson, Michele Stonier, Wendy Comisar, Deborah Panebianco, Sheila Breidinger, Jenny Zhang, and Richard Bertz. "Pharmacokinetics and Safety of Twice-daily Atazanavir 300 Mg and Raltegravir 400 Mg in Healthy Individuals." Antiviral Therapy 15, no. 8 (2010): 1107-1114. https://doi.org/10.3851/IMP1673.

MLA (9th ed.) Citation

Zhu, Li, et al. "Pharmacokinetics and Safety of Twice-daily Atazanavir 300 Mg and Raltegravir 400 Mg in Healthy Individuals." Antiviral Therapy, vol. 15, no. 8, 2010, pp. 1107-1114, https://doi.org/10.3851/IMP1673.